World News Insights
1-3 Minute Gist

All Topics Article

By Adding Patents, Drugmaker Keeps Cheaper Humira Copies Out of U.S.

WSJ Original article ›
LyrArc Article Gist
In a new twist drugmaker AbbieVie will bring out less costly versions of Humira in Europe where its patents have expired and still keep the U.S. market at higher Humira prices using a thicket of patents. Reports show pharmaceutical drug pricing as a major issue in U.S. midterm elections. Biologic drugs are costly. In this case Humira will sell at a 10-20% discount in Europe. Abbie Vie countered by getting hundreds of new patents in the U.S. to continue selling at high prices.


Innovation and the pricing of drugs in the U.S. by the pharmaceutical companies.

06/09/2007

Will drug innovation be affected adversely by price reductions in the USA? No say experts as it is a globalized industry and innovation takes place in labs around the world. And the pricing reforms, as in Britian and Germany, can actually encourage R&D for effective drugs with good cost relationships; when comparitive effectiveness of drugs and cost benefit analyses is used in pricing reforms. Pricing of pharmaceutical products and healthcare services is the major unsolved problem in the U.S.

Grouped Articles

The Soaring Cost of a Simple Breath

New York Times 10/12/2013

New Medicines Emerge, but Few Blockbusters

Wall Street Journal 12/16/2013

Health Care’s Road to Ruin

New York Times 12/21/2013

FDA Approves Cholesterol Drug From Regeneron, Sanofi

Wall Street Journal 07/25/2015

CEO who raised price of old pill more than $700 calls journalist a ‘moron’ for asking why - The Washington Post

Washington Post 09/22/2015

Settlement May Cut Drug Prices

Wall Street Journal 06/09/2007

Pricing of healthcare services and pharmaceuticals as the biggest problem in funding healthcare in the U.S.

01/31/2008

The cost of most healthcare services are double or higher in the U.S. than in Canada, Germany, France and Japan. By not bringing prices in line with the price in other major developed countries, the U.S. is effectively defunding infrastructure, R&D, education and other important means of improving competitiveness say experts. The methods of setting price present in these countries are notably absent in the U.S. The Obama healthcare bill and before that the Bush Medicare Prescription Drug Benefit simply leave this problem unaddressed.

Grouped Articles

Cuts Would Only Shift Health-Care Costs

Wall Street Journal 07/13/2011

Bayonne Medical Center Has Highest U.S. Billing Rates

New York Times 05/16/2013

The Soaring Cost of a Simple Breath

New York Times 10/12/2013

Health Care’s Road to Ruin

New York Times 12/21/2013

Economy Led to Cuts in Use of Health Care, Study Says

New York Times 08/16/2010

CEO who raised price of old pill more than $700 calls journalist a ‘moron’ for asking why - The Washington Post

Washington Post 09/22/2015


Support LyrArc

We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.

Support Lyrarc from as small as $1


Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us